Staar Surgical Says FDA May Take More Action
From Reuters
Staar Surgical Co., a maker of lenses and devices used in ophthalmology, said the Food and Drug Administration might take further action against it.
The FDA last year warned Staar it might suspend operations at its Monrovia plant because of flaws in the company’s surgically implanted contact lens.
Staar shares fell 25 cents to $6.15 on Nasdaq.
